Сравнение
Pasireotid vs. Triptorelin
Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.
Идентичность
Категория
Исследования (прочее)
Исследования (прочее)
Номер CAS
396091-73-9
57773-63-4
Молекулярная масса
1047.21 g/mol
1311.45 g/mol
Период полувыведения
нет данных
3 h
Последовательность
нет данных
pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2Механизм действия
Pasireotid
Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.
Triptorelin
Triptorelin binds with high affinity to the GnRH receptor in the pituitary. After initial stimulation of LH and FSH secretion (flare phase, about 1-2 weeks), receptor desensitisation follows with consecutive gonadotropin suppression. This results in a reversible chemical castration: in men testosterone, in women oestrogen suppression to the postmenopausal range.
Доказательная база
Наивысшая доказательность
РКИ на людях
РКИ на людях
Исследования
1
4
из них на людях
1
4
Зафиксированные эффекты
2
3
Открытые противоречия
0
0
Задокументированные нежелательные явления
2
3
Правовой статус
Полные записи
Frequently asked questions
- What is the difference between Pasireotid and Triptorelin?
- Pasireotid is classified as "Исследования (прочее)", while Triptorelin is classified as "Исследования (прочее)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Triptorelin: Synthetic decapeptide GnRH agonist with increased affinity over native gonadotropin-releasing hormone. FDA- and EMA-approved since the 1980s for prostate cancer, endometriosis and precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Pasireotid or Triptorelin?
- The highest available evidence level is "РКИ на людях" for Pasireotid and "РКИ на людях" for Triptorelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Pasireotid and Triptorelin in Germany and the United States?
- Германия: Pasireotid — Рецептурный, Triptorelin — Рецептурный. США: Pasireotid — Рецептурный, Triptorelin — Рецептурный. These are factual summaries with source and review date on the individual pages.